Skip to main content
. 2021 Sep 7;7:236. doi: 10.1038/s41420-021-00625-7

Fig. 6. Schematic of the mechanism of sitagliptin in improving liver inflammation.

Fig. 6

Specifically inhibiting the activity of DPP4 in hepatocytes by sitagliptin contributes to decreased activation of NFκB pathway and oxidative stress, as well as cell apoptosis under diabetic conditions. The ROS cleaning function of sitagliptin promotes the deactivation of NFκB pathway.